Beth Israel Deaconess Medical Center (BIDMC); the Harvard FXB Center for Health and Human Rights; and the Center for Climate, Health, and the Global Environment at the Harvard T.H. Chan School of Public Health (Harvard C-CHANGE), have launched a first-of-its-kind Climate and Human Health Fellowship.
BIDMC's Marc Schermerhorn, MD, Chief of the Division of Vascular and Endovascular Surgery, is available for interview to discuss why he feels strongly the AAA screening recommendations should be expanded to include other groups.
A paper published today in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, researchers at Beth Israel Deaconess Medical Center (BIDMC) shed new light on a genetic risk factor for Alzheimer’s disease that may indirectly influence patients’ risk of postoperative delirium.
In a new retrospective study published today in JAMA Internal Medicine, a team of researchers led by Rishi Wadhera, MD, MPP, MPhil, an investigator in the Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center (BIDMC), found that there are indeed striking disparities in in-hospital care and mortality between homeless and non-homeless adults.
Faculty from Beth Israel Deaconess Medical Center’s (BIDMC) CardioVascular Institute and colleagues will be presenting new advances and research at the 2019 American Heart Association (AHA) Scientific Sessions.
In light of Diabetes Awareness Month, John Giurini, DPM, Chief of Podiatric Surgery at Beth Israel Deaconess Medical Center (BIDMC), discusses how diabetes can cause problems with your feet.
Experts at Beth Israel Deaconess Medical Center share tips for quitting smoking
In a new study published today in JAMA Internal Medicine, a team of researchers led by Laura Burke, MD, MPH, an emergency medicine physician at BIDMC, found that among Medicare beneficiaries receiving ED care in the United States, mortality within 30 days of an ED visit has declined in recent years, particularly for the highest-severity patients.
In a paper published in Annals of Neurology, a physician-scientist at Beth Israel Deaconess Medical Center (BIDMC), and colleagues report the presence of cellular features consistent with an immune response targeting specialized brain cells in more than two thirds of autistic brains analyzed postmortem. These cellular characteristics – not previously observed in autism – lend critical new insight into autism’s origins and could pave the way to improved diagnosis and treatment for people with this disorder.
Barbara Masser, MD, Medical Director of Ambulatory Emergency Medicine at Beth Israel Deaconess Medical Center, shares some insight on whether or not you may need a flu test.
Dhruv S. Kazi, MD, MSc, MS, Associate Director of the Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center, writes an accompanying editorial about two new reports showing an association of dog ownership with a better outcome after a major cardiovascular event.
Ted James, MD, Chief of Breast Surgery and Co-Director of the BreastCare Center at Beth Israel Deaconess Medical Center, discusses the unique challenges women in their 20s and 30s face when diagnosed with breast cancer.
Monica Valero, MD, a breast surgical oncologist at the BreastCare Center at Beth Israel Deaconess Medical Center, discusses how breast cancer may impact women in their 20s and 30s.
Nadine Tung, MD, head of breast medical oncology and cancer genetics at Beth Israel Deaconess Medical Center, shares 5 things women under 40 should know about breast cancer
Jennifer Wilson, MD. a thoracic surgeon at Beth Israel Deaconess Medical Center, discusses vaping and your health
Researchers at Beth Israel Deaconess Medical Center demonstrated for the first time that a strong association between obesity and chronic diarrhea is not driven by diet or physical activity. The findings could have important implications for how physicians might approach and treat symptoms of diarrhea in patients with obesity differently.
Mutated KRAS genes are commonly found in several cancers and not all KRAS mutations in the same organ tissue cause the same disease severity, according to three new studies from researchers at the Cancer Center at Beth Israel Deaconess Medical Center.
A team of researchers at Beth Israel Deaconess Medical Center (BIDMC) evaluated whether it would be cost-effective to combine several medications into a single “cardiovascular polypill” for patients who have had a previous heart attack or stroke, instead of prescribing the four drugs individually.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right